Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADXN

Addex Therapeutics Ltd ADR

May 07 • 04:00PM ET

7.01

+0.16 2.34 %

Healthcare • Biotechnology • Switzerland • Nano • NASD

Peers: BIVI NERV ADIL CNSP DMAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.10	Insider Own	0.03%	Shs Outstand	0.98M	Perf Week	0.72%
Market Cap	8.83M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.98M	Perf Month	8.18%
Enterprise Value	6.80M	PEG	-	EPS next Q	-	Inst Own	0.04%	Short Float	0.74%	Perf Quarter	-8.96%
Income	-8.13M	P/S	44.16	EPS this Y	-	Inst Trans	47.92%	Short Ratio	1.50	Perf Half Y	-25.43%
Sales	0.20M	P/B	1.15	EPS next Y	-	ROA	-83.55%	Short Interest	0.01M	Perf YTD	-9.20%
Book/sh	6.12	P/C	4.27	EPS next 5Y	-	ROE	-99.18%	52W High	12.05 -41.83%	Perf Year	-13.14%
Cash/sh	1.64	P/FCF	-	EPS past 3/5Y	46.11% 31.85%	ROIC	-134.58%	52W Low	5.41 29.57%	Perf 3Y	-51.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-48.38% -44.27%	Gross Margin	-	Volatility	6.34% 7.51%	Perf 5Y	-96.46%
Dividend TTM	-	EV/Sales	34.01	EPS Y/Y TTM	-198.81%	Oper. Margin	-1662.79%	ATR (14)	0.54	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.40	Sales Y/Y TTM	-55.97%	Profit Margin	-3971.52%	RSI (14)	53.68	Recom	4.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.40	EPS Q/Q	-39.51%	SMA20	2.66%	Beta	1.52	Target Price	22.87
Payout	-	Debt/Eq	0.01	Sales Q/Q	1052.24%	SMA50	4.08%	Rel Volume	2.81	Prev Close	6.85
Employees	3	LT Debt/Eq	0.00	Earnings	Apr 30 BMO	SMA200	-13.22%	Avg Volume	4.84K	Price	7.01
IPO	Jan 29, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	13,179	Change	2.34%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)